TGFbeta pathobiology in the eye
- PMID: 16341020
- DOI: 10.1038/labinvest.3700375
TGFbeta pathobiology in the eye
Abstract
Transforming growth factor beta (TGFbeta), a multifunctional growth factor, is one of the most important ligands involved in the regulation of cell behavior in ocular tissues in physiological or pathological processes of development or tissue repair, although various other growth factors are also involved. Increased activity of this ligand may induce unfavorable inflammatory responses and tissue fibrosis. In mammals, three isoforms of TGFbeta, that is, beta1, beta2, and beta3, are known. Although all three TGFbeta isoforms and their receptors are present in ocular tissues, lack of TGFbeta2, but not TGFbeta1 or TGFbeta3, perturbs embryonic morphogenesis of the eyes in mice. Smads2/3 are key signaling molecules downstream of cell surface receptors for TGFbeta or activin. Upon TGF binding to the respective TGF receptor, Smads2/3 are phosphorylated by the receptor kinase at the C-terminus, form a complex with Smad4 and translocate to the nucleus for activation of TGFbeta gene targets. Moreover, mitogen-activated protein kinase, c-Jun N-terminal kinase, and p38 modulate Smad signals directly via Smad linker phosphorylation or indirectly via pathway crosstalk. Smad signals may therefore be a critical threrapeutic target in the treatment of ocular disorders related to fibrosis as in other systemic fibrotic diseases. The present paper reviews recent progress concerning the roles of TGFbeta signaling in the pathology of the eye.
Similar articles
-
Regulating the stability of TGFbeta receptors and Smads.Cell Res. 2009 Jan;19(1):21-35. doi: 10.1038/cr.2008.308. Cell Res. 2009. PMID: 19030025 Review.
-
Bone morphogenetic proteins.Growth Factors. 2004 Dec;22(4):233-41. doi: 10.1080/08977190412331279890. Growth Factors. 2004. PMID: 15621726 Review.
-
Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts.Arthritis Rheum. 2004 Dec;50(12):4008-21. doi: 10.1002/art.20658. Arthritis Rheum. 2004. PMID: 15593186
-
TGF-beta signal transduction in corneal wound healing as a therapeutic target.Cornea. 2004 Nov;23(8 Suppl):S25-30. doi: 10.1097/01.ico.0000136668.41000.73. Cornea. 2004. PMID: 15448476 Review.
-
Expression and action of transforming growth factor beta (TGFbeta1, TGFbeta2, TGFbeta3) in normal bovine ovarian surface epithelium and implications for human ovarian cancer.Mol Cell Endocrinol. 2001 Sep;182(2):145-55. doi: 10.1016/s0303-7207(01)00584-6. Mol Cell Endocrinol. 2001. PMID: 11514049
Cited by
-
Dental caries as a health risk for visual acuity in relation to salivary transforming growth factor beta-1 among students aged 8-10 years: A cross-sectional study.J Int Soc Prev Community Dent. 2024 Apr 29;14(2):144-151. doi: 10.4103/jispcd.jispcd_205_23. eCollection 2024 Mar-Apr. J Int Soc Prev Community Dent. 2024. PMID: 38827353 Free PMC article.
-
Lack of Elevated Expression of TGFβ3 Contributes to the Delay of Epithelial Wound Healing in Diabetic Corneas.Invest Ophthalmol Vis Sci. 2024 Mar 5;65(3):35. doi: 10.1167/iovs.65.3.35. Invest Ophthalmol Vis Sci. 2024. PMID: 38546583 Free PMC article.
-
Development and Verification of a Novel Three-Dimensional Aqueous Outflow Model for High-Throughput Drug Screening.Bioengineering (Basel). 2024 Jan 31;11(2):142. doi: 10.3390/bioengineering11020142. Bioengineering (Basel). 2024. PMID: 38391628 Free PMC article.
-
Lanosterol Synthase Prevents EMT During Lens Epithelial Fibrosis Via Regulating SREBP1.Invest Ophthalmol Vis Sci. 2023 Dec 1;64(15):12. doi: 10.1167/iovs.64.15.12. Invest Ophthalmol Vis Sci. 2023. PMID: 38079167 Free PMC article.
-
Basement membrane regeneration and TGF-β1 expression in rabbits with corneal perforating injury.Mol Vis. 2023 May 20;29:58-67. eCollection 2023. Mol Vis. 2023. PMID: 37287643 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous